Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Strong

Showing results (281-290 of 338) with videos related to

Pageof 34
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2017
Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPROGang Peng, Jasmina Bojadzieva, Mandy L Ballinger, et al.
Nature|October 2, 1983
Expression of recessive alleles by chromosomal mechanisms in retinoblastomaW K Cavenee, T P Dryja, R A Phillips, et al.
Cancer|December 15, 1980
Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study GroupA T Meadows, L C Strong, F P Li, et al.
Pediatric Blood & Cancer|December 21, 2012
Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencingBradford C Powell, Lichun Jiang, Donna M Muzny, et al.
Journal of the National Cancer Institute|December 21, 1988
Hepatoblastoma and familial adenomatous polyposisJ E Garber, F P Li, J E Kingston, et al.
The New England Journal of Medicine|September 3, 1987
Bone sarcomas linked to radiotherapy and chemotherapy in childrenM A Tucker, G J D'Angio, J D Boice, et al.
Plos One|June 4, 2010
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutationsShenying Fang, Ralf Krahe, Guillermina Lozano, et al.
Oncology Nursing Forum|December 31, 1997
Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancerP S Hinds, L Oakes, W Furman, et al.
Science (New York, N.Y.)|December 10, 1990
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmsD Malkin, F P Li, L C Strong, et al.
Medical and Pediatric Oncology|January 1, 1988
Educational achievement of long-term survivors of childhood and adolescent cancerJ Kelaghan, M H Myers, J J Mulvihill, et al.
Pageof 34

Showing results (281-290 of 338) with videos related to

Sort By:
Pageof 34
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2017
Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPROGang Peng, Jasmina Bojadzieva, Mandy L Ballinger, et al.
Nature|October 2, 1983
Expression of recessive alleles by chromosomal mechanisms in retinoblastomaW K Cavenee, T P Dryja, R A Phillips, et al.
Cancer|December 15, 1980
Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study GroupA T Meadows, L C Strong, F P Li, et al.
Pediatric Blood & Cancer|December 21, 2012
Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencingBradford C Powell, Lichun Jiang, Donna M Muzny, et al.
Journal of the National Cancer Institute|December 21, 1988
Hepatoblastoma and familial adenomatous polyposisJ E Garber, F P Li, J E Kingston, et al.
The New England Journal of Medicine|September 3, 1987
Bone sarcomas linked to radiotherapy and chemotherapy in childrenM A Tucker, G J D'Angio, J D Boice, et al.
Plos One|June 4, 2010
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutationsShenying Fang, Ralf Krahe, Guillermina Lozano, et al.
Oncology Nursing Forum|December 31, 1997
Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancerP S Hinds, L Oakes, W Furman, et al.
Science (New York, N.Y.)|December 10, 1990
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmsD Malkin, F P Li, L C Strong, et al.
Medical and Pediatric Oncology|January 1, 1988
Educational achievement of long-term survivors of childhood and adolescent cancerJ Kelaghan, M H Myers, J J Mulvihill, et al.
Pageof 34